BUY Suven Life Sciences Limited — Pankaj Randad
byPankaj RandadHorizon: NA (inferred Swing (≤2wk))15 Oct 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
RSI at 30 — oversold territory
Technicals · rsi·16 Oct · today
Past week's volume 1.8× the 30-day average
Technicals · volume·15 Oct · yesterday
Nothing found in this tip’s window yet.
MACD below its signal line — bearish momentum
Technicals · macd·16 Oct · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Suven Life Sciences
- BUY — Nilesh Jain, Centrum Broking24 Aug 2026 · ~3 months · target ₹390 · Target hit
- BUY — Sumeet Bagadia, Choice Broking17 Aug 2026 · ~2 weeks · target ₹370 · Target hit
- BUY — Sumeet Bagadia, Choice Broking11 Aug 2026 · ~2 weeks · target ₹365 · Target hit
More from Pankaj Randad
- BUY HBL Engineering16 Oct 2026 · ~2 weeks · target ₹820 · Target hit
- BUY JK Paper14 Oct 2026 · ~2 weeks · target ₹430 · Active
- BUY Tata Consultancy Services13 Oct 2026 · Same day · target ₹2,300 · Expired
- BUY Meesho13 Oct 2026 · ~2 weeks · target ₹255 · SL hit
- BUY Transformers And Rectifiers (India)13 Oct 2026 · ~2 weeks · target ₹338 · Target hit

